Healthcare

Few sectors reward innovation quite like healthcare. While miners search for discoveries underground and technology companies compete for customers, medical device developers are often judged by their ability to solve complex clinical challenges. That appears to be drawing attention to Anteris Technologies Global Corp …

Healthcare is increasingly moving beyond hospitals and clinics, with technology playing a larger role in how patients are assessed, monitored and supported. As digital health solutions continue to evolve, investors often look for smaller companies positioned within this growing segment. That appears to be …

ReNerve Limited (ASX:RNV) has taken another step in its commercial expansion strategy, announcing a distribution agreement with Malaysian medical device company UG Medical. ThePartnershipis designed to support the launch and commercialisation of ReNerve's NervAlign product range within Malaysia, a market that management views as …

The gain came as part of a sector-wide health care rally that spanned large-cap leaders such as CSL, ResMed and Cochlear as well as smaller medtech and biotech names. Saluda's participation reflected the building momentum behind medical-technology stocks as investors rotated toward the health …

The gain placed Cochlear among the session's prominent large-cap health care winners, alongside CSL, ResMed and Telix. With the major miners tumbling and the broader market down 0.70%, Cochlear's rise reflected the appetite for high-quality, defensive healthcare exposure as a shelter fromCommodity-drivenVolatility. The breadth …

The gain came as part of a sector-wide health care rally that spanned large-cap leaders such as CSL, ResMed and Cochlear as well as smaller biotech and emerging names. Mesoblast's participation in the rally reflected renewed investor appetite for biotech exposure asCapitalrotated toward the …

As one of the largest companies on the Australian market, CSL carries substantialindexweight, so its gain was particularly significant for the overall benchmark. Its strength, alongside other large-cap health care names such as ResMed, Cochlear and Telix, helped cushion the market against the sharp …